Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 12—December 2026
Dispatch
Mayaro Virus Emergence and Genetic Dynamics, Peru
Suggested citation for this article
Abstract
Mayaro virus (MAYV) is an emerging pathogen in Latin America. Using phylodynamic reconstructions and phylowave analyses, we describe novel lineage diversification and rapid dispersal of MAYV in Peru. A newly developed, dual-target quantitative reverse transcription PCR assay reliably detects MAYV variants, enabling improved surveillance, control, and understanding of this neglected arbovirus.
Mayaro virus (MAYV) is an endemic, neglected, zoonotic alphavirus (Togaviridae family) in Latin America and the Caribbean for which surveillance, diagnostic testing, and genomic data are limited. MAYV infections often are confused with other arboviral illnesses, and no licensed vaccine or specific antiviral treatment is available (1). MAYV causes acute and chronic arthritogenic disease (2) with fever, rash, and potentially year-long arthralgia (3). Typically maintained in the sylvatic cycle by the Haemagogus janthinomys mosquito and nonhuman primates (4), MAYV frequently spills over to humans (5). Experimental evidence suggests urban transmission is possible with Aedes aegypti and A. albopictus mosquitos (6). Increased reports of MAYV infection (7,8) led us to study the emergence and spread of new Mayaro strains in Peru.
We collected 1,000 whole blood specimens from patients encountered at 6 health facilities who had acute febrile illness (AFI) during September 2023–October 2024 (Appendix). We sequenced samples by using unbiased, metagenomic next-generation sequencing (NGS) and target-enriched NGS methods (9) (Appendix). We initially detected MAYV in 5 persons (5/1,000 [0.5%]) by using teamNGS, yielding 1 complete and 4 partial genome sequences with 13%–78% coverage (Table). BLAST analysis (https://blast.ncbi.nlm.nih.gov) indicated the sequences bore 99% nucleotide identity to a strain isolated from Peru in 2018 (GenBank accession no. KY026196). We inferred a maximum-likelihood phylogeny by using IQ-TREE2 (10) (Figure 1), placing all sequences from this study (GenBank accession nos. PZ530724–6) within MAYV genotype D, which splits into 2 monophyletic subclades. One subclade consists mostly of sequences from Peru, including those from patient samples APDC070024 and APDC070034, with a sequence from Colombia at its root. The other subclade shows a similar pattern for patient sample APDC060121. Those results suggest that MAYV diversification in Peru is driven by endemic evolution or repeated introductions, probably from Colombia.
Considering NGS sensitivity limitations and brief viremia periods, we developed a quantitative reverse transcription PCR to detect additional cases of MAYV infection and assess the role of MAYV in AFI in Peru. Our novel, dual-target molecular assay, guided by phylogenetic analysis (Figure 1), targets 2 conserved regions within the nonstructural protein 1 gene, both labeled in the Cy5 channel (Figure 2, panel A; Appendix Figure 1). The assay demonstrated linearity of 107–101 copies/reaction (R2 0.99; efficiency 90%) (Figure 2, panel B) and included an internal control for extraction and amplification validation (Figure 2, panel C). Analytical sensitivity (95% CI and probit analysis) indicated a limit of detection of ≈4 copies/reaction (Figure 2, panel D). We re-screened 1,000 samples from AFI patients on the Abbott m2000 platform (Abbott Molecular, https://www.molecular.abbott), confirming 5 previously identified positives and detecting 1 additional PCR-positive case missed by NGS (cycle threshold >28), consistent with the detection limits of target-enrichment NGS of log ≈3.0 copies/mL (Table).
By using phylodynamic and phylogeographic approaches (11), we next sought to understand which MAYV lineages are emergent, where they are originating from, and what is driving their expansion. In our temporal analysis using a Gaussian Markov random field prior (12), we traced the emergence of MAYV back to 1886, with an initial split of the 2 main genotypes occurring in 1897 (genotype L) and 1912 (genotype D) (Figure 3, panel A; Appendix Figure 2). The estimated evolutionary rate was 2.6 × 10−4 substitutions/site/year. The analysis also revealed that the cluster containing sequences from Trinidad and Tobago emerged around 1954, coinciding with the first reported case of MAYV infection (13), indicating accurate clock calibration in our dataset (Figure 3, panel A). Regarding Peru, we identified multiple clusters emerging at different timepoints, primarily 40–49 years ago. The cluster containing the APDC070034/Peru/02-08-2024 and APDC070024/Peru/02-01-2024 strains, which grouped with a strain from Columbia (GenBank accession no. PP505832), emerged approximately in 2010, and the ancestor for the APDC060121/Peru/03-18-2024 was circulating around 2007. The Bayesian Skyride reconstruction of the effective population size showed a steady increase in MAYV genetic diversity from around 1925 until 2005. After 2005, a sharp decrease in diversity occurred, reflecting the extinction of several genotype L strains. After that decrease, genetic diversity stabilized, potentially because of the emergence of novel genotype D strains (Figure 3, panel A).
A discrete phylogeographic reconstruction indicated that the root for MAYV emergence originated in Brazil, followed by 2 major dispersal pathways (Figure 3, panel B). The first pathway remained largely confined to Brazil before extending into Haiti (Figure 3, panel B). The second pathway spread from Brazil to Peru and subsequently underwent additional local expansions indicated by the discrete states at internal nodes, which involved Brazil, Trinidad and Tobago, Venezuela, Haiti, and Bolivia. From those foci, multiple exportation events spread into Central America. Those findings highlight the critical role of Brazil and Peru as sources for MAYV lineage evolution and dissemination across South and Central America.
The phylowave tool can recover known circulating lineages and previously unknown ones with considerable fitness advantages (14). Moreover, phylowave can agnostically monitor shifts in population composition, even when sequence availability is heavily biased. With this tool, we identified 3 distinct lineages in our dataset (Appendix Figure 3). Two of those (lineages 1 and 2) emerged in the 1930s–1940s, whereas the most recent lineage (lineage 3) arose in the late 1950s. Index value estimations suggest that lineage 1 might have been driven toward extinction, whereas lineages 2 and 3 exhibited cycles of dominance followed by inter-exchanges of lower frequencies. When we mapped the lineages onto our phylogenetic tree, we observed that lineage 1 originated in Brazil, spread to Trinidad and Tobago, and was later found in Louisiana (USA) in a bird sample (15) (Figure 3, panel B, C). In contrast, lineage 2 emerged in Brazil and mainly diversified there as well as Haiti and Peru, whereas lineage 3 originated in Peru but subsequently disseminated to countries such as Bolivia, Venezuela, and Brazil, always tracing back to Peru as its ultimate source (Figure 3, panel B, C). A phylowave-based fitness analysis also indicated that lineages 2 and 3 possess comparable genetic fitness, whereas lineage 1 exhibited a lack of fitness, accounting for its apparent path toward extinction (Figure 3, panel C; Appendix Figure 3).
We explored the spatial dispersal patterns of lineages 2 and 3 further by using continuous phylogeographic reconstruction (Appendix Figure 4). For lineage 2, the initial spread occurred between the late 1940s and early 1970s, predominantly confined to Bolivia and Brazil (Appendix Figure 4, panel A). After that phase, viral dispersal intensified in the late 1990s and early 2000s, reaching Venezuela, French Guiana, and Haiti. By contrast, lineage 3 appears to have been introduced into Peru around the late 1970s (Appendix Figure 4, panel B), subsequently spreading from Peru to Bolivia, Venezuela, Brazil, and Colombia from the early 1990s onward. Lineage 2 exhibited a median mean branch dispersal velocity of 10.85 (95% highest posterior density 6.51–21.66), whereas lineage 3 reached a median mean branch dispersal velocity of 40.24 (95% 95% highest posterior density 26.74–290.44). Consequently, lineage 3 appears to have spread >4 times faster than lineage 2, possessing a greater capacity to disseminate across South and Central America. This rapid dispersal could explain the elevated number of MAYV infection cases reported in the region and emphasizes the need to strengthen surveillance, particularly in Peru, where this lineage has emerged.
Our findings describe the genetic diversity and dispersal of MAYV across Latin America, highlighting Peru’s role in the spread of emerging lineages. The newly developed, dual-target quantitative reverse transcription PCR effectively detects those variants, enabling improved surveillance and control measures against MAYV, especially in regions with increasing case reports and ongoing spillover events.
Dr. Perez is a principal research scientist at Abbott Laboratories. His research interests include virus evolution, virus discovery, and molecular diagnostics.
References
- Lednicky JA, Ascanio LC, Cardoso S, Chace A, Paniz-Mondolfi AE. Mayaro virus in the Americas: a short review. In: Pujol FH, Paniz-Mondolfi AE, editors. Emerging viruses in Latin America: contemporary virology. Cham, Switzerland: Springer; 2024. p. 139–60.
- Acosta-Ampudia Y, Monsalve DM, Rodríguez Y, Pacheco Y, Anaya J-M, Ramírez-Santana C. Mayaro: an emerging viral threat? Emerg Microbes Infect. 2018;7:163. DOIPubMedGoogle Scholar
- Santiago FW, Halsey ES, Siles C, Vilcarromero S, Guevara C, Silvas JA, et al. Long-term arthralgia after Mayaro virus infection correlates with sustained pro-inflammatory cytokine response. PLoS Negl Trop Dis. 2015;9:
e0004104 . DOIPubMedGoogle Scholar - Wei LLL, Tom R, Kim YC. Mayaro virus: an emerging alphavirus in the Americas. Viruses. 2024;16:1297. DOIPubMedGoogle Scholar
- Celone M, Okech B, Han BA, Forshey BM, Anyamba A, Dunford J, et al. A systematic review and meta-analysis of the potential non-human animal reservoirs and arthropod vectors of the Mayaro virus. PLoS Negl Trop Dis. 2021;15:
e0010016 . DOIPubMedGoogle Scholar - Fernández D, Yun R, Zhou J, Parise PL, Mosso-González C, Villasante-Tezanos A, et al. Differential susceptibility of Aedes aegypti and Aedes albopictus mosquitoes to infection by Mayaro virus strains. Am J Trop Med Hyg. 2023;109:115–22. DOIPubMedGoogle Scholar
- Forato J, Meira CA, Claro IM, Amorim MR, de Souza GF, Muraro SP, et al. Molecular epidemiology of Mayaro virus among febrile patients, Roraima State, Brazil, 2018–2021. Emerg Infect Dis. 2024;30:1013–6. DOIPubMedGoogle Scholar
- Perez-Restrepo LS, Ciuoderis K, Usuga J, Moreno I, Vargas V, Arévalo-Arbelaez AJ, et al. Mayaro virus as the cause of acute febrile illness in the Colombian Amazon Basin. Front Microbiol. 2024;15:
1419637 . DOIPubMedGoogle Scholar - Redman SA, Perez LJ, Forberg K, Francis K, Walker JP, Thompson TK, et al. Dengue virus serotype 3 origins and genetic dynamics, Jamaica. Emerg Infect Dis. 2024;30:2149–54. DOIPubMedGoogle Scholar
- Nguyen L-T, Schmidt HA, von Haeseler A, Minh BQ. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol. 2015;32:268–74. DOIPubMedGoogle Scholar
- Pérez LJ, Baele G, Hong SL, Cloherty GA, Berg MG. Ecological changes exacerbating the spread of invasive ticks has driven the dispersal of severe fever with thrombocytopenia syndrome virus throughout Southeast Asia. Mol Biol Evol. 2024;41:
msae173 . DOIPubMedGoogle Scholar - Minin VN, Bloomquist EW, Suchard MA. Smooth skyride through a rough skyline: Bayesian coalescent-based inference of population dynamics. Mol Biol Evol. 2008;25:1459–71. DOIPubMedGoogle Scholar
- Anderson CR, Downs WG, Wattley GH, Ahin NW, Reese AA. Mayaro virus: a new human disease agent. II. Isolation from blood of patients in Trinidad, B.W.I. Am J Trop Med Hyg. 1957;6:1012–6. DOIPubMedGoogle Scholar
- Lefrancq N, Duret L, Bouchez V, Brisse S, Parkhill J, Salje H. Learning the fitness dynamics of pathogens from phylogenies. Nature. 2025;637:683–90. DOIPubMedGoogle Scholar
- Calisher CH, Gutiérrez E, Maness KS, Lord RD. Isolation of Mayaro virus from a migrating bird captured in Louisiana in 1967. Bull Pan Am Health Organ. 1974;8:243–8.PubMedGoogle Scholar
Figures
Table
Suggested citation for this article: Perez LJ, Hodges A, Torres K, Forberg K, Weiss S, Yamaguchi J, et al. Mayaro virus emergence and genetic dynamics, Peru. Emerg Infect Dis. 2026 Dec [date cited]. https://doi.org/10.3201/eid3212.251211
Original Publication Date: October 27, 2026
Table of Contents – Volume 32, Number 12—December 2026
| EID Search Options |
|---|
|
|
|
|
|
|



Please use the form below to submit correspondence to the authors or contact them at the following address:
Michael G. Berg, Abbott Laboratories, 100 Abbott Park Rd, Abbott Park, IL 60064, USA
Top